Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Nutr Metab Cardiovasc Dis. 2009 Apr 11;20(1):34. doi: 10.1016/j.numecd.2009.02.010

Table 3.

Effect of the CETP-TaqIB polymorphism on lipid concentrations and particle size*.

B2 carriers (n=676) B1/B1 (n=326)

Variable Mean ± SE Mean ± SE P
Total cholesterol, mmol/L 5.04±0.03 4.86±0.04 0.001
LDL cholesterol, mmol/L 3.22±0.02 3.09±0.04 0.005
HDL cholesterol, mmol/L 1.24±0.01 1.17±0.01 0.001
Triglycerides, mmol/L 1.26±0.01 1.26±0.01 0.942
HDL particle size, nm 8.87±0.01 8.81±0.01 0.022
LDL particle size, nm 20.84±0.03 20.65±0.51 0.003
VLDL particle size, nm 50.82±0.29 51.17±0.49 0.491
Large HDL, g/L 0.17±0.04 0.14±0.07 <0.001
Medium HDL, g/L 0.03±0.02 0.03±0.03 0.377
Small HDL, g/L 0.21±0.02 0.20±0.03 0.578
IDL, g/L 0.04±0.02 0.05±0.04 0.097
Large LDL, g/L 0.42±0.02 0.37±0.03 0.040
Small LDL, g/L 0.47±0.01 0.50±0.02 0.192
Medium small LDL, g/L 0.18±0.01 0.20±0.01 0.185
Very small LDL, g/L 0.28±0.01 0.32±0.01 0.032
Large VLDL, g/L 0.17±0.02 0.16±0.03 0.493
Medium VLDL, g/L 0.34±0.02 0.32±0.03 0.238
Small VLDL, g/L 0.12±0.03 0.12±0.06 0.520
*

Sample size of 996 for particle size (n=674 and 322 for B2 carriers and B1/B1, respectively). Values are mean ± SE.

P values were adjusted for age, gender, BMI, field center, physical activity, smoking habit, alcohol consumption, CHD, prior medications, hormone treatment, and family relationships.